Skip to content

Clinical trials

Terminated Phase 2/3 trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Terminated Country / region: Netherlands Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20063
20075
20082
20092
20115
20122
20131
20142
20158
20162
20172
20182
20191
20202
20213
20223
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated50

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
European Organisation for Research and Treatment of Cancer - EORTC3
Boehringer Ingelheim2
Erasmus Medical Center2
Facet Biotech2
Gilead Sciences2
Janssen Research & Development, LLC2
The Netherlands Cancer Institute2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Aerovate Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative4
Alzheimer Disease3
Breast Neoplasms2
COVID-192
Dementia2
Heart Failure2
Leiomyosarcoma2
Shock, Septic2
Adenocarcinoma of Lung1
Adenocarcinoma, Bronchiolo-Alveolar1

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.